RELX YUEKE Releases Social Responsibility Report 2021-2022

Sep.19.2022
RELX YUEKE Releases Social Responsibility Report 2021-2022
RELX releases its social responsibility report for 2021-2022, showcasing its efforts in market, product, environmental, employee, and corporate governance responsibilities.

On September 19, RELX Technology (formerly known as Shenzhen Kingtons Technology) – a company listed on the US stock market – released their "Confidence. Future – RELX Technology Social Responsibility Report 2021-2022." This report reviews the company's year-long progress towards fulfilling their social responsibilities and creating value for society, covering aspects such as market responsibility, product responsibility, environmental responsibility, employee responsibility, and corporate governance.


After more than four years of entrepreneurial endeavors, one of our most profound and satisfying experiences has been our unwavering commitment to fulfilling our social responsibilities. At YK, we view social responsibility as a core competitive advantage and an indispensable value for us as corporate citizens. This was expressed by YK's founder and CEO, Wang Ying.


This is the third consecutive year that Joyoung has released its corporate social responsibility report. Joyoung has updated its latest achievements in scientific research and development, patent applications, job creation, protection of minors, and combating counterfeit products in the report.


According to a report, Yooz is once again increasing its focus on product quality and vaporization science. Since its establishment, Yooz has invested over 800 million RMB in research and development. In 2022, Yooz will be upgrading its R&D system with an 8-lab matrix to further enhance product quality, flavor development, user experience, and scientific exploration, providing a complete technical path.


As of June 2022, Yueke has applied for over 610 patents worldwide, covering various aspects such as electronic atomizer design, atomized liquid formula, electronics, intelligence, and release safety. Many of these patents have significant breakthroughs in the industry.


This article contains excerpts or reprints from third-party sources, and their copyrights belong to the original media and author. If there is any infringement, please contact us for removal. Any organization or individual who needs to reproduce should contact the author and refrain from direct reproduction.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
A Fifth Circuit panel upheld the U.S. Food and Drug Administration’s 2021 final rule requiring companies seeking premarket authorization for new tobacco products to include information on health-risk investigations. In a published opinion, the court found FDA satisfied the Regulatory Flexibility Act’s procedural requirements and reasonably relied on the economic analysis from the 2016 “deeming rule” as a factual basis to certify limited impact on small businesses.
Feb.27 by 2FIRSTS.ai
Special Report|From Nicotine Pouches to Jelly? A China Tobacco Patent Explores Dual-Release NRT
Special Report|From Nicotine Pouches to Jelly? A China Tobacco Patent Explores Dual-Release NRT
A patent published on February 24, 2026, by China Tobacco Hubei Industrial Co., Ltd. introduces a “nicotine jelly” product designed to combine rapid and sustained nicotine delivery. By integrating both free and microencapsulated nicotine, the product aims to address key limitations of traditional nicotine replacement therapy (NRT), while also raising new regulatory and product classification questions.
Innovation
Mar.18
FDA nicotine pouch review delay report knocks tobacco shares lower
FDA nicotine pouch review delay report knocks tobacco shares lower
After Reuters reported before the market open that FDA reviews of nicotine pouch applications could face delays, shares of Philip Morris International, Turning Point Brands and British American Tobacco fell on April 1, underscoring the direct impact of U.S. regulatory signals on major tobacco companies and nicotine pouch expectations.
Apr.02
Elfbar warns flavour bans could push over 50,000 Scottish vapers back to smoking
Elfbar warns flavour bans could push over 50,000 Scottish vapers back to smoking
Elfbar said restricting vape flavour choices—potentially under the Tobacco and Vapes Bill—could disrupt established quitting behaviours and increase relapse risk among former smokers. An Opinium survey commissioned by the company reported fruit and sweet flavours have risen in popularity among adult vapers quitting smoking in Scotland, with 62% now using them most often to quit, up from 34% in December 2024.
Feb.28 by 2FIRSTS.ai
Patent Reveals China Tobacco Hubei Industrial Testing Animal Model for Heated Tobacco Safety Evaluation
Patent Reveals China Tobacco Hubei Industrial Testing Animal Model for Heated Tobacco Safety Evaluation
China Tobacco Hubei Industrial Co., Ltd. has published a patent describing a laboratory method to evaluate the reproductive and developmental safety of heated tobacco products using non-human animal exposure models. The approach introduces a structured toxicological testing framework that could support safety verification, quality control, and regulatory evidence generation for heated tobacco products.
Mar.09
Philip Morris and BAT’s Nicoventures Win EPO Appeal to Revoke VMR Vape Patent
Philip Morris and BAT’s Nicoventures Win EPO Appeal to Revoke VMR Vape Patent
The EPO Technical Board of Appeal 3.2.02 (T 1319/24) revoked VMR Products LLC’s EP3613453 “VAPORIZER” patent after finding that a 2012 YouTube video of the Innokin iTaste VV (D3) disclosed the claimed electrical contact arrangement. Opponents Nicoventures Trading Ltd (BAT subsidiary) and Philip Morris Products S.A. prevailed.
BATPMI
Feb.17